Roche’s new approval Enspryng cuts relapse risk in NMOSD—and provides extended benefits esagonowsky Thu, 09/10/2020 – 09:55 More: Roche's new approval Enspryng cuts relapse risk in NMOSD—and provides extended benefits Source: fierce
read moreAstraZeneca chases GSK, Sanofi and Regeneron with Fasenra trial win in nasal polyps aliu Thu, 09/10/2020 – 09:44 More: AstraZeneca chases GSK, Sanofi and Regeneron with Fasenra trial win in nasal polyps Source: fierce
read moreGlaxoSmithKline earns FDA nod for triple-drug combo Trelegy in sought-after asthma patients kblankenship Thu, 09/10/2020 – 08:37 More: GlaxoSmithKline earns FDA nod for triple-drug combo Trelegy in sought-after asthma patients Source: fierce
read moreTrelegy Ellipta is now the first once-daily single inhaler triple therapy for the treatment of both asthma and COPD in the US More: US expands scope of Trelegy Ellipta to include asthma Source: News
read moreThe EMA has asked for full data from an ongoing Phase III study of the treatment in patients with severe haemophilia A More: EU review extended for BioMarin's gene therapy Valrox Source: News
read moreThe proposed deal covers the initial supply of 200 million doses and an option to purchase an additional 100 million, with deliveries starting by the end of 2020, if the vaccine is approved More: Pfizer, BioNTech could supply EU with
read more© 1994 - 2026 B.M. Pharmaceuticals